TRX-818 sodium ( Foslinanib sodium )

产品货号. M11046 CAS No. 1256037-62-3

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

拼团产品询价大包装询价加入购物车

产品名称

TRX-818 sodium
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

TRX-818 sodium (Foslinanib sodium ) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
产品描述

TRX-818 sodium (Foslinanib sodium ) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities, induces cancer cell apoptosis and inhibits cancer cell proliferation; also prevents tumor cell VM by blocking the formation of vasculogenic-like tubular structures through an as of yet undetermined mechanism of action.Liver Cancer Phase 2 Clinical
同义词

Foslinanib sodium
通路

Others
靶点

Other Targets
受体

Other Targets
研究领域

Cancer
适应症

Liver Cancer

CAS Number

1256037-62-3
分子量

393.22
分子式

C16H11FNNa2O5P
纯度

>98% (HPLC)
溶解度

——
SMILES

COC1=C(C2=C(C=C1)NC(=CC2=O)C3=CC(=CC=C3)F)OP(=O)([O-])[O-].[Na+].[Na+]
化学全称

sodium (2-(3-fluorophenyl)-6-methoxy-4-oxo-1,4-dihydroquinolin-5-yl)phosphonate

计算器

产品手册

关联产品

Camelliaside B

Camelliaside B possesses deglycosylation activity.
Methyl nomilinate

Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
Kaempferidinidin chl...

Reference standards.